ASPIRE Study for Stroke Prevention and Recovery
Site for Anticoagulation in Intracerebral Hemorrhage (ICH) Survivors for Stroke Prevention and Recovery
- Sex: Any
- Age: Adult (18 - 64), Older Adult (65+)
- Accepting Healthy People: No
- Type: Others
- Trial Phase: NA
- Conditions Being Studied: Brain Cerebral Hemorrhage
Study Purpose
The purpose of this research study is to compare the effects of apixaban (also known as Eliquis®) with aspirin in patients with atrial fibrillation and a recent brain hemorrhage to see which is better in preventing strokes and death.
Who Can Participate
Participants 18 years and older experienced an intracerebral hemorrhage may be eligible for this study.
Locations
University Hospitals Mentor Health Center
9485 Mentor Ave.
Mentor OH, 44060
UH Minoff Health Center at Chagrin Highlands
3909 Orange Place
Orange Village OH, 44122
UH Ahuja Medical Center
3999 Richmond Road
Beachwood OH, 44122
UH Cleveland Medical Center
11100 Euclid Avenue
Cleveland OH, 44106
UH Westlake Health Center
960 Clague Road
Westlake OH, 44145
- UH IRB: SITE00001021
- StudyID: SITE00001021
- ClinicalTrials.gov: NCT03907046
Questions or concerns? We're here to help.
Non-cancer Trials: 1-833-78TRIAL or Contact Us Online
Cancer Trials: 1-800-641-2422